Infertility Treatment Market To Reach USD 3.6 Billion By 2032, Says DataHorizzon Research

Detailed analysis of infertility treatment market report. The growing incidence of infertility in the urban population has incurred the need for the best treatment solutions.


Fort Collins, Colorado, Oct. 12, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the infertility market size was valued at USD 1.7 Billion in 2022 and is expected to reach USD 3.6 Billion by 2032 at a CAGR of 8.1% from 2023 to 2032. 

Infertility occurs when a couple is unable to conceive a normal pregnancy. Also, infertility is becoming a common issue in the urban population, particularly because lifestyle and changing environmental factors such as obesity, smoking, and alcohol consumption adversely affect fertility. 

Hormonal disorders in both men and women also cause infertility. Ovulatory disorders like polycystic ovary disorder account for about 25 % of the infertility rate in women. Hormonal disorders, chromosomal abnormalities, and single-gene effects cause infertility in men. Infertility has no natural cure; it can be treated only through therapies and medications. For instance, medicinal drugs, surgeries, and in vitro fertilization are used to treat infertility issues.

Furthermore, the global fertility rate is declining steadily, which calls for increasing demand for infertility treatment products and services. According to World Fertility and Family Planning 2020, the global fertility rate fell from 3.2 to 2.5 live births per woman. The global fertility rate has decreased to 2.1 live births per woman. The declining fertility rate is driving the market for infertility treatment. In recent years, an increasing number of fertility centers and technological advancements like assisted reproductive technology (ART) to cure infertility have driven the infertility treatment market to a great extent.

Request Sample Report:

https://datahorizzonresearch.com/request-sample-pdf/infertility-treatment-market-2269

Segmentation Overview:

The global infertility treatment market has been segmented into product, procedure, end-user, and region. The media & consumable segment accounted for a significant market share in 2022. Consumable medications like tablets and oral pills are easily available and highly preferred by the end-users. Asia Pacific is anticipated to hold the highest market share until 2022. The infertile population is highest in Asia Pacific due to unhealthy lifestyles and delayed marriage. Factors like the rise in medical tourism, the increase in the number of fertility centers in the region, initiatives by the government for infertility treatment, and rising awareness among individuals are responsible for market dominance.

Buy This Research Report:

https://datahorizzonresearch.com/checkout-page/infertility-treatment-market-2269

Infertility Treatment Market Report Highlights:

  • The global infertility treatment market growth is anticipated at a CAGR of 8.1% by 2032.
  • Increased lifestyle changes, low preference for parenting, and irregular diet largely drive the infertility treatment market growth. Besides, the rise in cases of obesity has triggered the need for infertility treatments.
  • The women segment is also anticipated to dominate the market during the forecast period, attributing to the prevailing sedentary lifestyle, rise in alcohol consumption & smoking, and growing trend of delayed marriages, which causes complications in pregnancy and excessive use of contraceptives.
  • Assisted reproductive technology procedure is anticipated to grow fastest during the forecast period. With the advancement in technology, in-vitro fertilization techniques are prevailing and preferred by patients.
  • Some prominent players in the infertility treatment market report include Cook Group, Vitrolife, Thermo Fisher Scientrific, Inc., Genea Biomedx Ltd, The Cooper Companies Inc., Hamilton Thorne Ltd., ZEISS Group, and AB Scientific Ltd.

Industry Trends and Insights:

  • In 2022, Vios Fertility Institute partnered with TMRW Life Sciences after the launch of Cryo management solutions for fertility specimens. 
  • In 2023, medical startups have embraced AI solutions to deliver IVF treatments. For instance, Santaan, an India-based medical startup, has led this initiative by using AI solutions to enhance the accuracy of gamete selection in embryos and automate a few tasks to deliver a successful IVF. 

Looking Exclusively For Region/Country Specific Report?

https://datahorizzonresearch.com/ask-for-customization/infertility-treatment-market-2269

OR

Ask For Discount 

https://datahorizzonresearch.com/ask-for-discount/infertility-treatment-market-2269

Infertility Treatment Market Segmentation:

  • By Product: Equipment, accessories, media & consumables
  • By Procedure: Artificial insemination, assisted reproductive technology, fertility surgeries
  • By End-user: Men, women
  • By Region: North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. 

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.

Contact:

Mail: sales@datahorizzonresearch.com

Ph: +1-970-672-0390

Website: https://datahorizzonresearch.com/

Follow Us: LinkedIn 

 

Recent Publications

Liquid Biopsy Market 2023 to 2032
Hearing Aids Market 2023 to 2032
Exoskeleton Market 2023 to 2032
Active Pharmaceutical Ingredients Market 2023 to 2032
Gait Biometrics Market 2023 to 2032

 

Contact Data